The Global Pharmaceutical Logistics Market is experiencing growth by focused investments in cold chain infrastructure

The global pharmaceutical logistics market offers a wide range of transportation and warehousing services across various product categories such as pharmaceutical drugs, medical devices, clinical trial materials, and others. These products require strict temperature control and handling to maintain efficacy and safety throughout the supply chain. Key services provided include temperature-controlled transportation utilizing reefers or passive containers, cold and freezer warehousing, packaging support, radio frequency identification applications for real-time tracking, inventory control, and returns management. Regulatory compliance, serialization support, and storage of controlled substances are other critical aspects addressed by logistics providers.

The Global Pharmaceutical Logistics Market is estimated to be valued at US$ 99.7 billion in 2024 and is expected to exhibit a CAGR of 9.1% over the forecast period 2024 to 2031.

Stringent regulations pertaining to temperature control and quality for pharmaceuticals have compelled manufacturers to outsource logistics functions to specialized vendors having robust cold chain infrastructures and monitoring capabilities. This has augmented the market growth over the years.


Key Takeaways
Key players operating in The Global Pharmaceutical Logistics Market are Maersk, United Parcel Service of America, Inc., AWL India Private Limited, DHL Group, Kuehne+Nagel, DB Schenker, CEVA Logistics, SLB Performance, YUSEN LOGISTICS CO., LTD., NextPharma Logistics GmbH, Skandi, Movianto, Continental Carriers, Varuna Group, Sugamgroup, V-Xpress, Avvashya CCI Logistics Private Limited, Agility and Cencora, Inc.

The growth in the pharmaceutical industry and rising demand for healthcare products across the globe is fueling the pharmaceutical logistics market. Pharmaceutical logistics companies are experiencing heavy demand for their temperature controlled storage and transportation services.

Globalization of pharmaceutical supply chains has further expanded opportunities for international logistics providers. Market leaders are making focused investments and strategic partnerships or acquisitions to strengthen their multinational networks and cater to the growing cross-border trade of drugs and biologics.

Market Key Trends
Investments in digital logistics technology by major players is one of the key trends being witnessed in the global pharmaceutical logistics market. Advanced solutions for real-time cargo monitoring, predictive analytics, blockchain integrated platforms are being increasingly adopted. This enables logistics providers to handle complex inventories, optimize operational costs and improve delivery reliability and tracking visibility essential for pharmaceutical supply chains.

Porters five forces Analysis
Threat of new entrants: The pharmaceutical logistics industry requires large capital investments in transportation infrastructure and storage facilities. Regulatory compliances also make it difficult for new companies to enter this market.

Bargaining power of buyers: Pharmaceutical companies have significant bargaining power as logistics is a sizeable cost for them. They can negotiate on pricing and service quality.

Bargaining power of suppliers: Third party logistics providers have significant bargaining power due to their specialized knowledge and infrastructure. Switching costs for clients are also high.

Threat of new substitutes: There exists a moderate threat from alternative modes of transportation like air freight for time-critical shipments.

Competitive rivalry: The global pharmaceutical logistics market is highly fragmented with the presence of numerous international and domestic players.

Geographical Regions
North America accounts for the major share in the global pharmaceutical logistics market in terms of value due to high healthcare spending and early adoption of new drugs. The presence of several pharmaceutical manufacturers and distributors further drives the market in the region.

The Asia Pacific region is expected to grow at the fastest rate during the forecast period. Rapid economic development, increasing demand for pharmaceutical products, and expanding healthcare infrastructure are fueling market growth in emerging countries of Asia Pacific. China and India have emerged as major production and consumption markets for pharmaceuticals.


Comments

Post a Comment

Popular posts from this blog

Hypoglycemic Drugs Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Diabetes in the Geriatric Population

Image
Hypoglycemic drugs or anti-diabetic drugs are medications used to treat diabetes mellitus by lowering blood glucose levels. Some key hypoglycemic drugs include insulin, sulfonylureas, metformin, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and GLP-1 receptor agonists. These drugs help control blood sugar levels in diabetics and prevent or delay diabetes-related health complications. The global hypoglycemic drugs market is estimated to be valued at US$ 720.72 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The growth of the global hypoglycemic drugs market is majorly driven by the increasing prevalence of diabetes in the geriatric population globally. As per estimates, around 1 in every 11 people aged 65 years and above have diabetes. Further, the number of people with diabetes in this age group is anticipated to grow from 25.9 million in 2017 to...
Read more

Clinical Trials Rising with Digital Technologies Adoption

Image
 Clinical trials support services play a vital role in assisting sponsors and life science companies to conduct clinical trials in a precise and well-organized manner.These services assist pharmaceutical companies in patient recruitment, data management, site management, and overall clinical trial management. With rising complexities in clinical trials owing to integration of technologies like telehealth and remote patient monitoring, the demand for these support services is growing substantially. The global Clinical Trials Support Services Market is estimated to be valued at US$ 22.38 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The growing adoption of digital technologies across clinical trials is a key trend accelerating the growth of the clinical trials support services market. Digital tools like electronic data capture, clinical trial manag...
Read more

Vegan Yogurt Market is Poised for Growth Driven by Rising Health Consciousness

Image
Vegan yogurt is a dairy-free alternative to conventional yogurt made from plant-based milk such as soy, almond, oat, coconut or rice. It provides similar texture and taste to dairy yogurt but without any animal products.Vegan yogurt offers several health advantages over dairy yogurt as it is devoid of lactose, cholesterol and saturated fats. The growing number of people adopting vegan and flexitarian diets has driven the demand for plant-based dairy alternatives like vegan yogurt. The global vegan yogurt market is estimated to be valued at US$ 4.15 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031. Key Takeaways Key players- Met Fods, Cocos Organic, Hain Celestial, EasiYo Product Limited, Danone, General Mills Inc., Stonyfield Far, Inc., Daiya Foods Inc.m Good Karma foods, Inc.m Hudson River Foodsm NANCY'S, Kite Hill, COYO Pty lTd., Nush Foods, Chobani, LLC, Barambah Oraganics Pty Ltd., Blue Diamond Growers, Dean Foodsm General Mills Inc...
Read more